Cardiotox vs EchoGuide by ASE
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Cardiotox
Read full descriptionHide full description
Cardiotox® : The drug-induced/iatrogenic cardiotoxicity website & App The companion website and App Pneumotox ® addresses drug- and chemical-induced/iatrogenic pneumotoxicity. By Philippe Camus MD Professor (emeritus) (board-certified pulmonary medicine, cardiology) - Université Bourgone-Europe, Dijon, France. Cardiotox is an aid to the diagnosis and management of cardiotoxicity and cardiac reactions suspected of being induced by drugs, herbals, chemicals, radiation therapy and/or of iatrogenic origin.. Causality assessment and exact diagnosis are the full responsibility of the user. Cardiotox is designed to provide regularly-updated information on drugs causing cardiac toxicity (> 530), resulting patterns of involvement (> 400) and bibliography (3,950 references as of August 2026) within a few minutes. That may be the real crux in emergency situations, and enabling prompt withdrawal. Yet, double-checking in and from other sources is indicated. Cardiotox rests on a bibliographic repository of drug-induced pneumo- and cardiotoxicity built since 1978, that amounts to > 50,000 references as of August, 2026. The vast majority of these is indexed in PubMed. All references were and are still being carefully reviewed for reliability and causality by the founder, then indexed under the umbrella of the corresponding drug or agent. One can access Cardiotox by both causative drugs, chemicals, herbals, substances of abuse, inhalants, gases, radiation therapy and/or patterns of involvement. Drug names are generic (International Nonproprietary Names (INN), alphabetical), not brand. It may be appropriate to check the exact composition of any proprietary drug, as any other added substance or excipient can be toxic.Matching generic and brand names is country - dependent. Patterns are grouped by families according to the main anatomic site of involvement. If a drug or drug reaction is listed in Cardiotox, this does not equate the patient is demonstrating actual toxicity. A “Diagnosing DICD” window in Cardiotox can help fortify the diagnosis. Lack of case in the literature or in Cardiotox does not exclude a diagnosis of drug cardiotoxicity as there may be unpublished cases, you may be seeing the first case ever, or we may have overlooked some information. In such situations, Cardiotox or Pneumotox cannot be held responsible. At any rate, the founder of Cardiotox can be contacted by mail 7/7. A search for exposure to drugs, substances of abuse, and/or chemicals must be done exhaustively with the patient, family, health professionals, pharmacy and/or law enforcement personel. This can be life-saving, enabling appropriate drug withdrawal. Caution: Drug therapy withdrawal can cause flare of the background disease. Deliberate rechallenge of patient with the drug can be hazardous and lead to fatal consequences. Early sampling of body fluids for drugs and/or metabolites is indicated as early as possible, particularly in the severely ill. Knowledge of toxidromes and antidotes to combat them is also precious. Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies. They may host more and/or undisclosed information. Patients should be reassured as such incidents are rare. If needed, they are invited to consult with their treating physicians or via Cardiotox. You may contact Cardiotox through the contact window. ALL RIGHTS RESERVED The current version of Cardiotox website and App were developed by Akyos Communication, Dijon, France Pneumotox received a generous Grant from the ERS in 2019
EchoGuide by ASE
This medical app offers over 50 calculators, algorithms, and charts based on key guidelines for cardiac care professionals. It allows users to favorite interactive tools for quick access to a wide range of echocardiography measurements and assessments.
- Over 50 calculators, algorithms, and charts
- Based on ASE guidelines
- Favorite interactive tools
- Cardiac care reference
- Echocardiography measurements
Read full descriptionHide full description
ASE’s EchoGuide provides access to over 50 calculators, algorithms, and charts. EchoGuide was developed based on key ASE guidelines for use by healthcare professionals providing cardiac care. One special feature in the app is that users have the ability to select their favorite interactive tools for easy access. Topics include: • Left Ventricle • Left Ventricle Mass • Left Ventricular Diastolic Function • Right Ventricle • Left Atrium • Right Atrium Dimensions & Volumes • Aorta • Aortic Regurgitation • Aortic Stenosis • Mitral Regurgitation • Mitral Stenosis • Tricuspid Regurgitation • Tricuspid Stenosis • Pulmonic Regurgitation • Pulmonic Stenosis • Prosthetic Aortic Valve Function • Prosthetic Mitral Valve Function • Prosthetic Tricuspid Valve Function • Prosthetic Pulmonic Valve Function • Prosthetic Valve Regurgitation EchoGuide is intended for educational/informational use only. EchoGuide is not intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease by aiding clinical decision-making. Please send feedback through the App information page and feel free to leave a review and rating in the App Store.
Screenshots
Verdict
The clearest difference is update cadence: EchoGuide by ASE at monthly against Cardiotox's every 35 months. EchoGuide by ASE also leads on iOS requirement (14.2 vs 16.4). On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Cardiotox ships an update every 35 months, EchoGuide by ASE monthly. The most recent releases landed on November 3, 2026 and November 16, 2026 respectively.
| Parameter | Cardiotox | EchoGuide by ASE |
|---|---|---|
| Price | Free | Free |
| Rating | — | 4.7 (41 ratings) — better |
| Positive reviews | — | 75.0% of reviews |
| Number of ratings | — | 41 — better |
| Update frequency | Every 35 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | — | Free |
| Devices | iPhone, iPad | iPhone, iPad, iPod — better |
| Requires iOS | 16.4 | 14.2 — better |
| Further details — not scored | ||
| Size | 54 MB | 96 MB |
| Age rating | 17+ | 12+ |
| Developer | Philippe Camus | American Society of Echocardiography |
In-app purchases
Cardiotox
No in-app purchases
EchoGuide by ASE
No in-app purchases
Questions
Is Cardiotox free?
Is EchoGuide by ASE free?
Do Cardiotox or EchoGuide by ASE have ads?
Which is updated more often, Cardiotox or EchoGuide by ASE?
Other comparisons















